173 related articles for article (PubMed ID: 21248041)
1. Vital role for CD8+ cells in controlling retroviral infections.
Kane M; Case LK; Golovkina TV
J Virol; 2011 Apr; 85(7):3415-23. PubMed ID: 21248041
[TBL] [Abstract][Full Text] [Related]
2. Replication of beta- and gammaretroviruses is restricted in I/LnJ mice via the same genetic mechanism.
Case LK; Petell L; Yurkovetskiy L; Purdy A; Savage KJ; Golovkina TV
J Virol; 2008 Feb; 82(3):1438-47. PubMed ID: 18057254
[TBL] [Abstract][Full Text] [Related]
3. Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies.
Purdy A; Case L; Duvall M; Overstrom-Coleman M; Monnier N; Chervonsky A; Golovkina T
J Exp Med; 2003 Jan; 197(2):233-43. PubMed ID: 12538662
[TBL] [Abstract][Full Text] [Related]
4. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular basis of the retrovirus resistance in I/LnJ mice.
Case LK; Purdy A; Golovkina TV
J Immunol; 2005 Dec; 175(11):7543-9. PubMed ID: 16301663
[TBL] [Abstract][Full Text] [Related]
6. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
[TBL] [Abstract][Full Text] [Related]
7. Filariae-Retrovirus Co-infection in Mice is Associated with Suppressed Virus-Specific IgG Immune Response and Higher Viral Loads.
Dietze KK; Dittmer U; Koudaimi DK; Schimmer S; Reitz M; Breloer M; Hartmann W
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005170. PubMed ID: 27923052
[TBL] [Abstract][Full Text] [Related]
8. B Cell Requirement for Robust Regulatory T Cell Responses to Friend Retrovirus Infection.
Moore TC; Gonzaga LM; Mather JM; Messer RJ; Hasenkrug KJ
mBio; 2017 Aug; 8(4):. PubMed ID: 28765225
[TBL] [Abstract][Full Text] [Related]
9. Role of T-cell subsets in acute and persistent E-55+ murine leukemia virus infection in susceptible progressor and resistant long-term nonprogressor mouse strains. Women and Infants Transmission Study.
Avidan N; Sieck TG; Blank KJ
Clin Immunol Immunopathol; 1997 Dec; 85(3):282-8. PubMed ID: 9400628
[TBL] [Abstract][Full Text] [Related]
10. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.
Santiago ML; Benitez RL; Montano M; Hasenkrug KJ; Greene WC
J Immunol; 2010 Jul; 185(2):1114-23. PubMed ID: 20566830
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.
Nasser R; Pelegrin M; Michaud HA; Plays M; Piechaczyk M; Gros L
J Virol; 2010 Oct; 84(19):10169-81. PubMed ID: 20610721
[TBL] [Abstract][Full Text] [Related]
12. Prolonged E55+ retrovirus expression in aged mice is associated with a decline in the anti-virus immune response.
elRefaei M; Blank KJ; Murasko DM
Virology; 2001 Nov; 290(2):281-9. PubMed ID: 11883192
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob.
Denzin LK; Khan AA; Virdis F; Wilks J; Kane M; Beilinson HA; Dikiy S; Case LK; Roopenian D; Witkowski M; Chervonsky AV; Golovkina TV
Immunity; 2017 Aug; 47(2):310-322.e7. PubMed ID: 28813660
[TBL] [Abstract][Full Text] [Related]
14. Myd88 is required for an antibody response to retroviral infection.
Browne EP; Littman DR
PLoS Pathog; 2009 Feb; 5(2):e1000298. PubMed ID: 19214214
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of resistance to mouse mammary tumor virus infection.
Golovkina TV
J Virol; 2000 Mar; 74(6):2752-9. PubMed ID: 10684291
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T cells complement antibodies in protecting against yellow fever virus.
Bassi MR; Kongsgaard M; Steffensen MA; Fenger C; Rasmussen M; Skjødt K; Finsen B; Stryhn A; Buus S; Christensen JP; Thomsen AR
J Immunol; 2015 Feb; 194(3):1141-53. PubMed ID: 25539816
[TBL] [Abstract][Full Text] [Related]
17. Gradual elimination of retroviruses in YBR/Ei mice.
MacDearmid CC; Case LK; Starling CL; Golovkina TV
J Virol; 2006 Mar; 80(5):2206-15. PubMed ID: 16474128
[TBL] [Abstract][Full Text] [Related]
18. Passive immunization with neutralizing antibodies interrupts the mouse mammary tumor virus life cycle.
Mpandi M; Otten LA; Lavanchy C; Acha-Orbea H; Finke D
J Virol; 2003 Sep; 77(17):9369-77. PubMed ID: 12915552
[TBL] [Abstract][Full Text] [Related]
19. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
